drugset / Trial / NCT05299567
Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans
RandomizedParallel-groupDouble-blindTreatment
Summary
Placebo-controlled, double-blind, randomized study. Post-infectious bronchiolitis obliterans (PIBO) patients aged 5 years and older of both sexes were enrolled.
Timeline
- Start
- 2010-08-24
- Primary completion
- 2011-07-21
- Completion
- 2011-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | — |
| Comparator | Azithromycin | Small molecule | 500 mg | — |